Product Overview
General Information
- Product Name
- Alpha GPC 600 mg
- Brand
- Dr. Tobias Products in this brand
- Bar Code
- 8 42367 00376 4
- Net Contents
- 60 Capsules
- Market Status
- On Market
- Date entered into DSLD
- 29 October 2026
- DSLD ID
- s43049
Product Classification
Label Information
Supplement Facts
- Daily Value (DV) Target Group(s)
- —
- Serving Size
- 2 Capsules
- Alternate Serving Size
- —
- Servings per Container
- 30
| Alpha GPC 50% (as L-alpha-glycerylphosphorylcholine) | 600 mg | ** |
Other ingredients: Microcrystalline Cellulose, dicalcium phosphate, silicified microcrystalline cellulose, hypromellose, magnesium stearate.
Label Statements
Suggested/Recommended/Usage/Directions: SUGGESTED USE: As a dietary supplement, take 2 capsules 4 times daily with 8-12 oz of water or as directed by your healthcare professional.
Precautions re: All Other: CAUTION: For healthy individuals 18 years and older. Consult a healthcare professional prior to use if you are pregnant or nursing, taking medication, or have a medical condition. WARNING: Reproductive Harm - www.P65Warnings.ca/gov/food
Precautions re: All Other: KEEP OUT OF REACH OF CHILDREN. DO NOT USE IF SAFETY SEAL IS DAMAGED OR MISSING. STORE IN A COOL, DRY PLACE.
FDA Disclaimer Statement: *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand Information
Source: Reverse Age Lab, October 2026
More labels from Dr. Tobias
Other labels with this ingredient
Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.


